ArticleTherapeutic advances in medical oncology2021

A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2- metastatic breast cancer.

Yi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.